A3P Switzerland congress in March 2025
The A3P Switzerland congress in March 2025 will delve into the interpretation and application of the new Annex 1 in Switzerland, with a focus on sharing practical insights and experiences from the industry. Since the publication of Annex 1 Manufacture of Sterile Medicinal Products and its implementation on August 23 with PICs PE 009-17, the pharmaceutical and biotechnology sectors have been faced significant changes in process design, aseptic practices and contamination control requirements. This forum will provide a unique opportunity to discuss Swissmedic’s interpretation of these new requirements and to examine the strategies and challenges encountered by industry leaders in their implementation efforts. Participants will gain insight into compliance expectations and innovative approaches to meet the stringent standards now required for the manufacture of sterile and low microbial load medicinal products.